A 39-year-old HIV-positive black African woman with previously treated cerebral toxoplasmosis experienced a foetal intra-uterine death due to congenital toxoplasmosis. This case demonstrates the complexities of screening for maternal toxoplasmosis in the context of pregnancy and HIV infection-related cell-mediated immunosuppression. Additionally, the case highlights the challenges in providing effective preventative and therapeutic drug options for congenital toxoplasmosis.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1177/0956462418773955 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!